NCT07076069 The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair
| NCT ID | NCT07076069 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Montefiore Medical Center |
| Condition | Rotator Cuff Repairs |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2025-07-21 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 130 participants in total. It began in 2025-07-21 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to understand which group of pain control medications work best in adults after rotator cuff surgery.
Eligibility Criteria
Inclusion Criteria: * Adults with rotator cuff tears who have failed conservative therapy and are now undergoing arthroscopic rotator cuff repair. Exclusion Criteria: * Patients without capacity to consent for the study * Patients not able to have local nerve block * Patients who underwent previous shoulder surgery on the same side, kindling revision rotator cuff repair * Patients who are unable to record and verbalize their pain level due to altered mental status * Patients who are unable to tolerate any of the medications included in the multimodal pain regimen or standard pain regimen due to severe allergies or inability to consume medication * Patients with history of previously diagnosed alcohol or drug abuse, renal impairment, peptic ulcer disease, and gastrointestinal bleeding * Patients who are pregnant
Contact & Investigator
Ferdinand Chan, M.D.
PRINCIPAL INVESTIGATOR
Montefiore Medical Center
Frequently Asked Questions
Who can join the NCT07076069 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rotator Cuff Repairs. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07076069 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07076069 currently recruiting?
Yes, NCT07076069 is actively recruiting participants. Contact the research team at fchan@montefiore.org for enrollment information.
Where is the NCT07076069 trial being conducted?
This trial is being conducted at The Bronx, United States.
Who is sponsoring the NCT07076069 clinical trial?
NCT07076069 is sponsored by Montefiore Medical Center. The principal investigator is Ferdinand Chan, M.D. at Montefiore Medical Center. The trial plans to enroll 130 participants.